Quick Answer
Tectonic Therapeutic, Inc. reported Net Income Loss of -$74.15 million for the year ending 2025.
- Tectonic Therapeutic, Inc. showed a decrease of -27.9% in Net Income Loss from 2024 to 2025.
- This data is from Tectonic Therapeutic, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: -$2.53 million | Q3 2017: -$6.44 million | Q1 2018: -$8.24 million | Q2 2018: -$10.51 million | Q3 2018: -$11.59 million | Q1 2019: -$17.10 million | Q2 2019: -$16.06 million | Q3 2019: -$17.15 million | Q1 2020: -$25.97 million | Q2 2020: -$28.83 million | Q3 2020: -$36.78 million | Q1 2021: -$26.90 million | Q2 2021: -$31.39 million | Q3 2021: -$32.61 million | Q1 2022: -$29.83 million | Q2 2022: -$28.05 million | Q3 2022: -$22.97 million | Q1 2023: -$14.45 million | Q2 2023: -$10.46 million | Q3 2023: -$10.05 million | Q1 2024: -$15.22 million | Q2 2024: -$12.67 million | Q3 2024: -$17.72 million | Q1 2025: -$15.91 million | Q2 2025: -$19.98 million | Q3 2025: -$19.04 million.
- Over the full 9 years of available data (2017 to 2025), Tectonic Therapeutic, Inc.'s Net Income Loss has declined by 297.6%.
- Historical annual values: Fiscal year 2025: -$74.15 million | Fiscal year 2024: -$57.98 million | Fiscal year 2023: -$42.82 million | Fiscal year 2022: -$105.89 million | Fiscal year 2021: -$119.13 million | Fiscal year 2020: -$119.71 million | Fiscal year 2019: -$72.97 million | Fiscal year 2018: -$46.36 million | Fiscal year 2017: -$18.65 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: